Welcome to the E-newsletter of the Nebraska Coalition for Lifesaving Cures March, 2016! Below are a few articles that caught our eye this month. Enjoy.
We are also excited to announce that our new and improved website is up and running!
FDA moves to crack down on unproven stem cell therapies
Federal regulators are preparing to crack down on scores of clinics across the United States that offer pricey stem cell therapies for conditions ranging from autism to multiple sclerosis to erectile dysfunction without any scientific evidence that they work.
As many as 200 stem cell clinics have cropped up in recent years, peddling injections, facelifts, and treatments for a number of devastating conditions. They have avoided heavy regulation, in part because they use cells extracted from a patient’s own body and because they don’t do much to those cells before reinjecting them.
Read more here.
ViaCyte on the Rise: First Diabetes Trial Data & Acquired BetaLogics IP
Clinical research on Type I Diabetes is one of the most exciting and promising areas of stem cells and regenerative medicine for human disease.
Two of the coolest companies out there in this arena have been ViaCyte and BetaLogics (owned by J&J). For more on ViaCyte see my interview with President and CEO Paul Laikind from 2015.
Read more here.
Stem Cell Battles: Proposition 71 and Beyond by Don C Reed
As reviewed on Amazon: This is a one-of-a-kind book: combining easy-to-understand science, in-the-trenches political warfare, and inspirational stories. It aims to give hope to individuals and families who suffer from chronic disease or disability; to point out how ordinary people can make an extraordinary difference in the battle to ease suffering and save lives through supporting medical research…
Read more here.
Stem Cell on Valentine’s Day: Update on Cardiac Regenerative Medicine
Can stem cells mend a broken heart?
The idea of the use of stem cells and regenerative medicine strategies for heart disease has taken us on a roller coaster ride over the years.
There are many controversial questions still such as whether the adult heart has meaningful populations of endogenous stem cells. Can administration of stem cells help a damaged heart?
Read more here.
US stem cell clinic sued for injection into patient’s eyes: landmark case?
For the first time to my knowledge, a patient has sued an American stem cell clinic alleging damage to her eyes from fat stem cell injections. Just a few months ago, there was a report of a Japanese patient who sued a fat stem cell clinic and won, but I’m not aware of a similar case in the US until now.
Elizabeth Noble, who reportedly received a stem cell injection into her eyes for macular degeneration by U.S. Stem Cell, Inc., has filed suit against the company…
Read more here.
Upcoming Events
